Global Synthetic Peptide Vaccine Market Research Report 2021

1 Synthetic Peptide Vaccine Market Overview

• 1.1 Product Overview and Scope of Synthetic Peptide Vaccine
• 1.2 Synthetic Peptide Vaccine Segment by Type
  • 1.2.1 Global Synthetic Peptide Vaccine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Solution Phase Synthesis (SPS)
  • 1.2.3 Solid Phase Peptide Synthesis (SPPS)
• 1.3 Synthetic Peptide Vaccine Segment by Application
  • 1.3.1 Global Synthetic Peptide Vaccine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Prostate Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastric Cancer
  • 1.3.5 Lung Cancer
  • 1.3.6 Pancreatic Cancer
  • 1.3.7 Others
• 1.4 Global Synthetic Peptide Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Synthetic Peptide Vaccine Revenue 2016-2027
  • 1.4.2 Global Synthetic Peptide Vaccine Sales 2016-2027
  • 1.4.3 Synthetic Peptide Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Synthetic Peptide Vaccine Market Competition by Manufacturers

• 2.1 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Synthetic Peptide Vaccine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Synthetic Peptide Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Synthetic Peptide Vaccine Market Competitive Situation and Trends
  • 2.5.1 Synthetic Peptide Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Synthetic Peptide Vaccine Players Market Share by Revenue
  • 2.5.3 Global Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Synthetic Peptide Vaccine Retrospective Market Scenario by Region

• 3.1 Global Synthetic Peptide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Synthetic Peptide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Synthetic Peptide Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Synthetic Peptide Vaccine Sales by Country
  • 3.3.2 North America Synthetic Peptide Vaccine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Synthetic Peptide Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Synthetic Peptide Vaccine Sales by Country
  • 3.4.2 Europe Synthetic Peptide Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Synthetic Peptide Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Synthetic Peptide Vaccine Sales by Region
  • 3.5.2 Asia Pacific Synthetic Peptide Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Synthetic Peptide Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Synthetic Peptide Vaccine Sales by Country
  • 3.6.2 Latin America Synthetic Peptide Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Synthetic Peptide Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Synthetic Peptide Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Synthetic Peptide Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Synthetic Peptide Vaccine Historic Market Analysis by Type

• 4.1 Global Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)
• 4.2 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2016-2021)
• 4.3 Global Synthetic Peptide Vaccine Price by Type (2016-2021)

5 Global Synthetic Peptide Vaccine Historic Market Analysis by Application

• 5.1 Global Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)
• 5.2 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2016-2021)
• 5.3 Global Synthetic Peptide Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Anergis
  • 6.1.1 Anergis Corporation Information
  • 6.1.2 Anergis Description and Business Overview
  • 6.1.3 Anergis Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Anergis Synthetic Peptide Vaccine Product Portfolio
  • 6.1.5 Anergis Recent Developments/Updates
• 6.2 Antigen Express
  • 6.2.1 Antigen Express Corporation Information
  • 6.2.2 Antigen Express Description and Business Overview
  • 6.2.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Antigen Express Synthetic Peptide Vaccine Product Portfolio
  • 6.2.5 Antigen Express Recent Developments/Updates
• 6.3 Apitope Technology
  • 6.3.1 Apitope Technology Corporation Information
  • 6.3.2 Apitope Technology Description and Business Overview
  • 6.3.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Apitope Technology Synthetic Peptide Vaccine Product Portfolio
  • 6.3.5 Apitope Technology Recent Developments/Updates
• 6.4 Artificial Cell Technologies
  • 6.4.1 Artificial Cell Technologies Corporation Information
  • 6.4.2 Artificial Cell Technologies Description and Business Overview
  • 6.4.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio
  • 6.4.5 Artificial Cell Technologies Recent Developments/Updates
• 6.5 Benovus Bio
  • 6.5.1 Benovus Bio Corporation Information
  • 6.5.2 Benovus Bio Description and Business Overview
  • 6.5.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Benovus Bio Synthetic Peptide Vaccine Product Portfolio
  • 6.5.5 Benovus Bio Recent Developments/Updates
• 6.6 Celgene Corporation
  • 6.6.1 Celgene Corporation Corporation Information
  • 6.6.2 Celgene Corporation Description and Business Overview
  • 6.6.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Celgene Corporation Synthetic Peptide Vaccine Product Portfolio
  • 6.6.5 Celgene Corporation Recent Developments/Updates
• 6.7 Immatics biotechnologies
  • 6.6.1 Immatics biotechnologies Corporation Information
  • 6.6.2 Immatics biotechnologies Description and Business Overview
  • 6.6.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio
  • 6.7.5 Immatics biotechnologies Recent Developments/Updates
• 6.8 Merck
  • 6.8.1 Merck Corporation Information
  • 6.8.2 Merck Description and Business Overview
  • 6.8.3 Merck Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Merck Synthetic Peptide Vaccine Product Portfolio
  • 6.8.5 Merck Recent Developments/Updates
• 6.9 ImmunoCellular Therapeutics
  • 6.9.1 ImmunoCellular Therapeutics Corporation Information
  • 6.9.2 ImmunoCellular Therapeutics Description and Business Overview
  • 6.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio
  • 6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
• 6.10 ISA Pharmaceuticals
  • 6.10.1 ISA Pharmaceuticals Corporation Information
  • 6.10.2 ISA Pharmaceuticals Description and Business Overview
  • 6.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio
  • 6.10.5 ISA Pharmaceuticals Recent Developments/Updates
• 6.11 Lytix Biopharma
  • 6.11.1 Lytix Biopharma Corporation Information
  • 6.11.2 Lytix Biopharma Synthetic Peptide Vaccine Description and Business Overview
  • 6.11.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio
  • 6.11.5 Lytix Biopharma Recent Developments/Updates
• 6.12 Spotlight Innovation
  • 6.12.1 Spotlight Innovation Corporation Information
  • 6.12.2 Spotlight Innovation Synthetic Peptide Vaccine Description and Business Overview
  • 6.12.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio
  • 6.12.5 Spotlight Innovation Recent Developments/Updates
• 6.13 OncoTherapy Science
  • 6.13.1 OncoTherapy Science Corporation Information
  • 6.13.2 OncoTherapy Science Synthetic Peptide Vaccine Description and Business Overview
  • 6.13.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio
  • 6.13.5 OncoTherapy Science Recent Developments/Updates
• 6.14 Peptech
  • 6.14.1 Peptech Corporation Information
  • 6.14.2 Peptech Synthetic Peptide Vaccine Description and Business Overview
  • 6.14.3 Peptech Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Peptech Synthetic Peptide Vaccine Product Portfolio
  • 6.14.5 Peptech Recent Developments/Updates
• 6.15 Pharmasyntez
  • 6.15.1 Pharmasyntez Corporation Information
  • 6.15.2 Pharmasyntez Synthetic Peptide Vaccine Description and Business Overview
  • 6.15.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Pharmasyntez Synthetic Peptide Vaccine Product Portfolio
  • 6.15.5 Pharmasyntez Recent Developments/Updates
• 6.16 Sumitomo Dainippon Pharma
  • 6.16.1 Sumitomo Dainippon Pharma Corporation Information
  • 6.16.2 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Description and Business Overview
  • 6.16.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio
  • 6.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
• 6.17 TapImmune
  • 6.17.1 TapImmune Corporation Information
  • 6.17.2 TapImmune Synthetic Peptide Vaccine Description and Business Overview
  • 6.17.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 TapImmune Synthetic Peptide Vaccine Product Portfolio
  • 6.17.5 TapImmune Recent Developments/Updates
• 6.18 Targovax
  • 6.18.1 Targovax Corporation Information
  • 6.18.2 Targovax Synthetic Peptide Vaccine Description and Business Overview
  • 6.18.3 Targovax Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Targovax Synthetic Peptide Vaccine Product Portfolio
  • 6.18.5 Targovax Recent Developments/Updates

7 Synthetic Peptide Vaccine Manufacturing Cost Analysis

• 7.1 Synthetic Peptide Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Synthetic Peptide Vaccine
• 7.4 Synthetic Peptide Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Synthetic Peptide Vaccine Distributors List
• 8.3 Synthetic Peptide Vaccine Customers

9 Synthetic Peptide Vaccine Market Dynamics

• 9.1 Synthetic Peptide Vaccine Industry Trends
• 9.2 Synthetic Peptide Vaccine Growth Drivers
• 9.3 Synthetic Peptide Vaccine Market Challenges
• 9.4 Synthetic Peptide Vaccine Market Restraints

10 Global Market Forecast

• 10.1 Synthetic Peptide Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Type (2022-2027)
• 10.2 Synthetic Peptide Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Application (2022-2027)
• 10.3 Synthetic Peptide Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List